The interventional oncology market is segmented into five major regions, namely North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Europe accounted for the second-largest share in 2018. The rising incidence of cancer, coupled with the growing geriatric population in Europe, is a key factor propelling the demand for interventional oncology products in this region. Prominent market players are focusing on improving the quality of patient care across Europe by commercializing advanced products, investing in technological innovations, and partnering with other institutions and organizations for spreading cancer awareness.
This report studies the interventional oncology market based on products, procedure, cancer type, and region. The report also studies factors such as drivers, restraints, opportunities, and challenges affecting market growth. It also provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to four main regions and the respective countries in these regions.
Growth in the interventional oncology market can be attributed to factors such as the rising preference for minimally invasive procedures, expansion of the target patient population, and increasing public-private funding and government support for cancer research. On the other hand, the dearth of well-trained and skilled radiologists and oncologists, high costs of interventional oncology procedures, and unfavorable regulations are expected to limit market growth to a certain extent.
This report focuses on various levels of analysis—industry trends, market shares of top players, and company profiles, which together form basic views. It also analyzes the competitive landscape; emerging segments of the interventional oncology market; and high-growth regions and their drivers, restraints, challenges, and opportunities. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner greater market shares.
Moreover, the study showcases back-to-back parameters like application, improvement, product growth, and diverse structures & key processes. The report highlights the in-depth analysis of various critical parameters such as profit & loss statistics, product value, production capability, production process, and many more.
The Interventional Oncology Market report delivers a perfect solution, which incorporates current market intelligence, future projections for the growth, technology inputs, and future market trends.
The report focuses on key strategic developments, analytical tools, and market feature. The report exhibits a top to the bottom estimate of the Interventional Oncology Market which includes key patterns, key players, market drivers, challenges, arrangement patterns, openings, esteem chain, professional outlines, and future guide.
The interventional oncology market is projected to reach USD 2.9 billion by 2024 from USD 2.0 billion in 2019, at a CAGR of 6.8%.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=203687164
The major players operating in the interventional oncology market include BTG plc (UK), Medtronic (Ireland), Boston Scientific (US), Terumo (Japan), Merit Medical (US), Sirtex (China), AngioDynamics (US), Ethicon (US), Teleflex (US), Cook Medical (US), HealthTronics (US), MedWaves (US), Sanarus (US), IMBiotechnologies (Canada), Trod Medical (US), IceCure Medical (Israel), Mermaid Medicals (Denmark), Interface Biomaterials BV (Netherlands), Guerbet (France), ABK Biomedical (Canada), Shape Memory Medical (US), Endo Shape (US), Monteris Medical (US), Instylla (US), and Trisalus Lifesciences (US).
This research study involved the extensive use of secondary sources, directories, and databases (such as D&B Hoovers, Bloomberg Businessweek, and Factiva), along with government databases, which were used to identify and collect information for this method-based, market-oriented, and commercial study of the interventional oncology market.
In-depth interviews were conducted with various primary respondents that mainly include key industry participants, medical practitioners, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants to obtain and verify critical qualitative and quantitative information as well as to assess prospects of the interventional oncology market.
Interventional Oncology Market, by Product
- Embolization Devices
- Radioembolic Agents
- Non-radioactive Embolic Agents
- Ablation Devices
- Radiofrequency Ablation Devices
- Microwave Ablation Devices
- Cryoablation Devices
- Other Ablation Devices
- Support Devices
- Microcatheters
- Guidewires
Interventional Oncology Market, by Procedure
- Thermal Tumor Ablation
- Non-thermal Tumor Ablation
- Transcatheter Arterial Chemoembolization (TACE)
- Transcatheter Arterial Radioembolization (TARE) or Selective Internal Radiation Therapy (SIRT)
- Transcatheter Arterial Embolization (TAE) or Bland Embolization
Interventional oncology Market, by Cancer Type
- Liver Cancer
- Kidney Cancer
- Lung Cancer
- Bone Cancer
- Other Cancers
